Ecolab Inc. vs Reliance, Inc. — Stock Comparison
Q·Score Breakdown
6.6
Neutral
Overall
6.6
Neutral
Quality
Health
Growth
Valuation
Sentiment
ECL
High-quality business with 22% return on equity and 13% profit margins.
⚠ balance sheet warrants attention.
RS
Clean balance sheet with low leverage (0.3× debt-to-equity).
⚠ cautious analyst consensus — few Buy ratings.
Analyst Consensus
BUY
Target $317.48 (+22.3%)
21 analysts
HOLD
Target $357.75 (-2.2%)
8 analysts
Fundamentals
ECL
RS
35.1×
Trailing P/E
23.9×
27.1×
Forward P/E
17.5×
12.8%
Profit Margin
5.4%
44.4%
Gross Margin
28.7%
22.4%
ROE
11.3%
10.0%
Revenue Growth
15.5%
7.8%
Earnings Growth
36.4%
1.02
Beta
0.87
—
Price / Book
—
$73.3B
Market Cap
$18.7B
$249 – $309
52-Week Range
$260 – $368
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →